Medicina y salud
Disciplina temática
Northwestern University
Evanston, Estados UnidosPublicaciones en colaboración con investigadores/as de Northwestern University (38)
2024
-
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
Nature Genetics, Vol. 56, Núm. 1, pp. 27-36
2023
-
Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinson's Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
npj Parkinson's Disease
-
Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
npj Parkinson's Disease, Vol. 9, Núm. 1
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
2022
-
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
Nature Communications, Vol. 13, Núm. 1
2021
-
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit
Schizophrenia Research, Vol. 227, pp. 10-17
-
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Neuropsychopharmacology, Vol. 46, Núm. 8, pp. 1468-1474
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial
The Lancet, Vol. 394, Núm. 10194, pp. 219-229
-
CD160 serves as a negative regulator of NKT cells in acute hepatic injury
Nature Communications, Vol. 10, Núm. 1
-
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT
Cellular and Molecular Immunology, Vol. 16, Núm. 7, pp. 679-682
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2017
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2015
-
Quest for missing proteins: Update 2015 on chromosome-centric human proteome project
Journal of Proteome Research, Vol. 14, Núm. 9, pp. 3415-3431
-
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome
Journal of Proteome Research, Vol. 14, Núm. 2, pp. 603-608
2014
-
Clinical laboratory immunology: An indispensable player in laboratory medicine
American Journal of Clinical Pathology, Vol. 142, Núm. 4, pp. 437-444
-
Inaccuracy of haemoglobin A1c among HIV-infected men: Effects of CD4 cell count, antiretroviral therapies and haematological parameters
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 12, pp. 3360-3367